Merios
Metabolic Health

HOMA-IR: The Insulin Resistance Score Your Doctor Never Calculates

What HOMA-IR is, how to calculate it from a basic blood test, what the optimal ranges are, and why it catches metabolic problems years before fasting glucose.

OCT 12, 20269 MIN READMETABOLIC HEALTHMERIOS EDITORIAL
Contents
  1. What HOMA-IR tells you
  2. The HOMA-IR formula
  3. HOMA-IR reference ranges
  4. Why this matters: the timeline of metabolic disease
  5. What drives HOMA-IR higher
  6. Visceral fat
  7. Physical inactivity
  8. Poor sleep
  9. Chronic stress
  10. Dietary patterns
  11. Genetics
  12. How to improve your HOMA-IR
  13. 1. Build muscle
  14. 2. Zone 2 cardio
  15. 3. Reduce refined carbohydrates
  16. 4. Prioritize sleep
  17. 5. Manage stress
  18. 6. Lose visceral fat
  19. How to get your HOMA-IR tested
  20. How Merios helps
  21. Sources

There is a number that strongly predicts your metabolic future.1 It takes two data points from a fasting blood test, a simple equation, and 10 seconds of math. Yet almost no doctor calculates it.

It is called HOMA-IR — Homeostatic Model Assessment of Insulin Resistance — and it may be the most useful metabolic metric you have never heard of.

What HOMA-IR tells you

Your body runs on glucose. To get glucose from the blood into cells, it needs insulin. When cells respond well to insulin, you need only a small amount to clear glucose efficiently. When cells become resistant — due to excess visceral fat, inactivity, poor sleep, chronic stress, or genetic predisposition — the pancreas has to produce more insulin to get the same job done.2

HOMA-IR quantifies this relationship.3 It asks: given your fasting glucose level, how much insulin is your body producing to maintain it?

A low score means your body is efficient — low insulin, low glucose. A high score means your pancreas is working hard, even if your glucose appears normal on paper.

The HOMA-IR formula

The calculation is straightforward:

HOMA-IR = (Fasting Glucose in mg/dL × Fasting Insulin in µIU/mL) ÷ 4054

You need both numbers from a fasting blood draw (at least 8 hours without food). Here are some real examples:

Fasting glucoseFasting insulinHOMA-IRAssessment
85 mg/dL4 µIU/mL0.84Excellent sensitivity
90 mg/dL6 µIU/mL1.33Optimal
95 mg/dL10 µIU/mL2.35Borderline resistant
100 mg/dL15 µIU/mL3.70Insulin resistant
110 mg/dL22 µIU/mL5.98Significant resistance

Notice something critical in this table: the first two people have fasting glucose values that any doctor would call normal (85 and 90 mg/dL). The difference between them and the third person only becomes visible when you add insulin to the picture.

HOMA-IR reference ranges

HOMA-IR scoreInterpretation
Below 1.0Excellent insulin sensitivity
1.0–1.5Optimal — target range for longevity
1.5–2.0Normal — acceptable but worth tracking
2.0–2.5Borderline insulin resistance
2.5–3.5Insulin resistance — action needed
3.5–5.0Significant insulin resistance
Above 5.0Severe insulin resistance / metabolic syndrome

These bands are a rough guide, not a clinical standard: HOMA-IR values depend on the insulin assay, and research cut-offs for insulin resistance vary with age, sex and ethnicity — population studies have proposed values from under 2 to about 3.5.45 Some metabolic health experts argue that trouble begins below 2.5 — and one population study that anchored its cut-off to metabolic syndrome put it at about 2.0.6

Why this matters: the timeline of metabolic disease

Type 2 diabetes does not appear overnight. It follows a progression that typically unfolds over many years — in the Whitehall II cohort, insulin sensitivity was already falling steeply 5 years before diagnosis:7

Phase 1 — Silent compensation (HOMA-IR rising, glucose normal) Your cells are becoming resistant. Your pancreas compensates by producing more insulin. Fasting glucose stays in the 80–95 mg/dL range. Standard blood work shows nothing wrong. But HOMA-IR is climbing — from 1.0 to 1.5 to 2.5.

Phase 2 — Impaired fasting glucose (glucose 100–125 mg/dL) The pancreas cannot fully compensate anymore. Glucose begins to creep up. This is "pre-diabetes." By this point, you have likely been insulin resistant for years.

Phase 3 — Type 2 diabetes (glucose 126 mg/dL or higher) Beta cell function has declined substantially — by over 80%, by one leading estimate.2 Glucose management is failing. Medications are often needed.

HOMA-IR catches the problem in Phase 1. Fasting glucose catches it in Phase 2. HbA1c confirms it in Phase 2–3. The earlier you intervene, the easier it is to reverse.

What drives HOMA-IR higher

Visceral fat

The fat stored around your organs — liver, pancreas, intestines — is metabolically active tissue that secretes inflammatory cytokines (TNF-α, IL-6) which directly impair insulin signaling.8 Visceral fat is one of the strongest predictors of insulin resistance. You can be at a "normal" BMI and still have excess visceral fat (this is sometimes called "TOFI" — thin outside, fat inside).9

Physical inactivity

Skeletal muscle is responsible for most insulin-stimulated glucose disposal — roughly 90% in clamp studies.10 When muscles are inactive, they downregulate GLUT4 transporters — the channels that allow glucose to enter the cell. Inactivity alone is enough: a week of bed rest made healthy young men insulin resistant, with less GLUT4 in their muscle.11

Poor sleep

Sleep restriction — even just a few nights of 5–6 hours — increases insulin resistance acutely: a week of 5-hour nights cut insulin sensitivity by about 20% in healthy men.12 Another study found that restricting sleep to 4 hours for 6 nights lowered glucose tolerance in healthy young men.13 Sleep apnea and shift work are both linked to insulin resistance or type 2 diabetes.1415

Chronic stress

Cortisol promotes gluconeogenesis (the liver releasing glucose into the blood) and directly antagonizes insulin action.16 Chronic psychological stress predicts new-onset type 2 diabetes, with sustained cortisol elevation one likely pathway.17 This may be one reason HOMA-IR can be elevated even in lean, active individuals who are under constant stress.

Dietary patterns

Diets high in refined carbohydrates, sugar-sweetened beverages, and processed foods cause repeated large insulin spikes.18 Over time, cells downregulate their response — high insulin is both a result and a driver of insulin resistance.19 The liver becomes a particular problem: excess fructose and carbohydrate drive hepatic de novo lipogenesis (the liver converting sugar to fat), leading to fatty liver, which further worsens insulin resistance.20

Genetics

Some people have a genetic predisposition to insulin resistance. A variant near IRS1 affects insulin signaling and is linked to insulin resistance and high insulin, while common TCF7L2 variants raise diabetes risk mainly by impairing insulin secretion.2122 Family history of type 2 diabetes is one of the strongest risk factors23 — but it is a risk factor, not a destiny. Lifestyle still modifies the expression: in the Diabetes Prevention Program, the extra risk from TCF7L2 looked smaller in the lifestyle group.22

How to improve your HOMA-IR

The good news: HOMA-IR responds well to lifestyle change. In trials, interval training lowered insulin resistance,24 and viscous fiber cut HOMA-IR by about 1.9 points in people with type 2 diabetes.25

1. Build muscle

Resistance training 3–4 times per week increases muscle mass and glucose uptake capacity.26 Each kilogram of skeletal muscle added is another glucose sink that reduces the burden on insulin.27 Compound movements (squats, deadlifts, rows, presses) are the most efficient.

2. Zone 2 cardio

150+ minutes per week of zone 2 exercise (60–70% max heart rate — the pace where you can still hold a conversation) improves mitochondrial density and fat oxidation.2829 This is the metabolic base that makes everything else work better.

3. Reduce refined carbohydrates

You do not need to go zero-carb. But replacing refined grains, sugary beverages, and processed snacks with whole foods, vegetables, and complex carbohydrates makes a measurable difference.30 Prioritize meals that combine protein, fat, and fiber — this blunts the glucose spike.18

4. Prioritize sleep

Aim for 7–8 hours of quality sleep.31 Address sleep apnea if present. Keep a consistent sleep schedule. Limit screen exposure before bed. Sleep is not a luxury — it is insulin's best friend.

5. Manage stress

Chronic stress management — whether through exercise, meditation, social connection, or simply reducing overcommitment — can lower cortisol, which directly opposes insulin.16 In people with diabetes, psychosocial interventions have modestly improved A1C.32

6. Lose visceral fat

If you carry excess visceral fat, even a 5–10% reduction in body weight can markedly improve insulin sensitivity in liver, muscle and fat tissue.33 The combination of resistance training + caloric deficit + adequate protein (muscle gains from training plateaued at about 1.6 g per kg body weight a day in trials) is a well-supported approach.34

How to get your HOMA-IR tested

You need a fasting blood draw that includes both fasting glucose and fasting insulin. Here is the practical path: If you do not have a fasting insulin result, the TyG index calculator estimates insulin resistance from triglycerides and glucose alone.

  1. Ask your doctor to add fasting insulin to your next blood panel. Most will agree if you explain why.
  2. Order it yourself through Quest Diagnostics, LabCorp, or similar direct-to-consumer lab services in the US.
  3. Calculate it using the HOMA-IR calculator or the formula above, or let Merios do it automatically.

Test in the morning after 10–12 hours of fasting. Avoid intense exercise the evening before, as it can acutely lower insulin.35 Get tested at roughly the same time of day for comparable results.

How Merios helps

Upload your blood panel to Merios and we automatically extract fasting glucose and fasting insulin, calculate your HOMA-IR, and track it over time. See how your metabolic health responds to changes in exercise, diet, sleep, and stress — all in one dashboard alongside your Apple Watch data.

Calculate your HOMA-IR with Merios →


This article is for informational purposes only and does not constitute medical advice. Discuss metabolic health screening with your physician.

Sources

35 references · checked October 12, 2026

  1. Song Y, Manson JE, Tinker L, et al. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study. Diabetes Care, 2007.PMID 17468352DOI
  2. Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes, 2009.PMID 19336687DOI
  3. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985.PMID 3899825DOI
  4. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care, 2004.PMID 15161807DOI
  5. Tahapary DL, Pratisthita LB, Fitri NA, et al. Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes Metab Syndr, 2022.PMID 35939943DOI
  6. Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord, 2013.PMID 24131857DOI
  7. Tabák AG, Jokela M, Akbaraly TN, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet, 2009.PMID 19515410DOI
  8. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 2006.PMID 17167471DOI
  9. Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol, 2019.PMID 31301983DOI
  10. DeFronzo RA, Gunnarsson R, Björkman O, et al. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest, 1985.PMID 3894418DOI
  11. Biensø RS, Ringholm S, Kiilerich K, et al. GLUT4 and glycogen synthase are key players in bed rest-induced insulin resistance. Diabetes, 2012.PMID 22403297DOI
  12. Buxton OM, Pavlova M, Reid EW, et al. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes, 2010.PMID 20585000DOI
  13. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet, 1999.PMID 10543671DOI
  14. Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol, 2004.PMID 15353412DOI
  15. Gan Y, Yang C, Tong X, et al. Shift work and diabetes mellitus: a meta-analysis of observational studies. Occup Environ Med, 2015.PMID 25030030DOI
  16. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab, 1982.PMID 7033265DOI
  17. Hackett RA, Steptoe A. Type 2 diabetes mellitus and psychological stress - a modifiable risk factor. Nat Rev Endocrinol, 2017.PMID 28664919DOI
  18. Holt SH, Miller JC, Petocz P. An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods. Am J Clin Nutr, 1997.PMID 9356547DOI
  19. Shanik MH, Xu Y, Skrha J, et al. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?. Diabetes Care, 2008.PMID 18227495DOI
  20. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest, 2009.PMID 19381015DOI
  21. Rung J, Cauchi S, Albrechtsen A, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet, 2009.PMID 19734900DOI
  22. Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med, 2006.PMID 16855264DOI
  23. Scott RA, Langenberg C, Sharp SJ, et al. The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia, 2013.PMID 23052052DOI
  24. Jelleyman C, Yates T, O'Donovan G, et al. The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev, 2015.PMID 26481101DOI
  25. Jovanovski E, Khayyat R, Zurbau A, et al. Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care, 2019.PMID 30617143DOI
  26. Holten MK, Zacho M, Gaster M, et al. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes, 2004.PMID 14747278DOI
  27. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab, 2011.PMID 21778224DOI
  28. Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA, 2018.PMID 30418471DOI
  29. Toledo FG, Menshikova EV, Ritov VB, et al. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes. Diabetes, 2007.PMID 17536063DOI
  30. Evert AB, Dennison M, Gardner CD, et al. Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Diabetes Care, 2019.PMID 31000505DOI
  31. About Sleep. Centers for Disease Control and Prevention, 2024.
  32. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2025. Diabetes Care, 2025.PMID 39651983DOI
  33. Magkos F, Fraterrigo G, Yoshino J, et al. Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. Cell Metab, 2016.PMID 26916363DOI
  34. Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med, 2018.PMID 28698222DOI
  35. Mikines KJ, Sonne B, Farrell PA, et al. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol, 1988.PMID 3126668DOI

Frequently asked questions

  • What is HOMA-IR?
    HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It is a simple calculation using your fasting glucose and fasting insulin to estimate how resistant your cells are to insulin. The formula is: (Fasting Glucose in mg/dL × Fasting Insulin in µIU/mL) ÷ 405. A higher number means more insulin resistance.
  • What is a normal HOMA-IR score?
    There is no universal standard — cut-offs vary by population and by the insulin assay a lab uses. As a rough guide, a HOMA-IR below 1.0 indicates excellent insulin sensitivity, between 1.0 and 1.5 is considered optimal, and between 1.5 and 2.0 is normal but worth monitoring. Research cut-offs for insulin resistance range from under 2 to about 3.5, with 2.5 often quoted. Longevity physicians prefer to see HOMA-IR below 1.5.
  • How do I calculate my HOMA-IR?
    You need two numbers from a fasting blood test: fasting glucose (in mg/dL) and fasting insulin (in µIU/mL). Multiply them together, then divide by 405. For example: fasting glucose of 95 mg/dL × fasting insulin of 8 µIU/mL = 760 ÷ 405 = 1.88. That sits in the normal-but-worth-monitoring range, below common research cut-offs for insulin resistance.
  • Can I lower my HOMA-IR?
    Yes. HOMA-IR is highly modifiable through lifestyle. The most effective interventions are regular exercise (especially resistance training and zone 2 cardio), reducing refined carbohydrates, improving sleep quality, managing stress, and losing excess visceral fat. HOMA-IR often improves within months of consistent changes, though how far it falls varies from person to person.
Keep reading

More from the Journal

Metabolic Health

Fasting Insulin Levels Chart: Normal, Optimal and High Ranges

Fasting insulin chart by age and sex. Why it's a better metabolic marker than fasting glucose, and what optimal levels look like for longevity.

APR 17, 202610 MIN READ
Metabolic Health

Type 2 Diabetes vs LADA: How Blood Tests Tell Them Apart

Type 2 diabetes vs LADA: learn how GAD antibodies and C-peptide blood tests differentiate these conditions and affect treatment.

APR 24, 20267 MIN READ
Metabolic Health

Fasting Glucose 100 or 110 mg/dL: Borderline or Prediabetic?

Fasting glucose of 100 to 125 mg/dL is prediabetes. What 100 and 110 mean, how fast each tends to progress, and how to bring the number back down.

APR 30, 20265 MIN READ
Newsletter

Like this? Get the next one in your inbox.

Merios is live on the US App Store — plus a weekly briefing with new biomarker deep-dives and plain-English study breakdowns.

Get the app